Infection Control Market worth $14.0 Billion by 2017
kerryfido 51 Views
The overall infection control market will grow at a steady pace of around 6% and will reach $14.0 billion by 2017 from $10.5 billion in 2012
Browse 192 market data tables with 11 figures spread through 356 pages and in-depth TOC on “Infection Control Market [Sterilization (EtO Sterilization, E-Beam, Gamma, Steam, Low Temperature, Contract Services) and Disinfection (Endoscope Reprocessing, Disinfectant, Disinfector, Face Mask, Drapes, Surgical Gowns, Wipes) – Global Forecast To 2017.”
Early buyers will receive 10% customization on reports.
This report studies the global infection control over the forecast period of 2012 to 2017.
The report focuses on sterilization (heat, chemical, radiation and filtration) and disinfection (disinfectors, endoscope reprocessing, disinfectants, medical non-wovens and disinfectant wipes) technologies. It also studies sterilization services market, which includes healthcare solutions, hospital sterilization services, and applied sterilization technologies. The sterilization applications market includes medical device, pharmaceuticals, life sciences, food, and other applications such as cosmetics.
The global infection control market will grow at a steady pace of around 6% from $10.5 billion in 2012 to $14.0 billion by 2017. The rise in tide of cleaning standards and mounting pressure for sterilized and disinfected medical devices in hospitals and clinics has triggered the growth of medical sterilization and disinfection market. The increase in hospital acquired infections or nosocomial infections have forced the medical authorities to take stringent regulatory actions to curb these infections with the use of sterilized and disinfected medical devices.
In disinfection market, the endoscope reprocessing segment continues to grow due to an increased importance to diagnostic and therapeutic endoscopy procedures, rising minimally invasive surgeries and concerns regarding patient-to-patient cross infection caused due to improper endoscopes reprocessing.
The infection control will grow at a steady pace of around 6% and will reach $14.0 billion by 2017 from $10.5 billion in 2012. The major players in this market are Getinge (Sweden), Steris (U.S.), Medivators (U.S.), Advanced Sterilization Product (U.S.), 3M (U.S.), Belimed (Switzerland), Cardinal Health (U.S.), Kimberly-Clark (U.S.), Sterigenics (U.S.), Sakura (Japan), Synergy Health (U.K.) and Nordion (Canada).
Other articles you might like;
North - Dominion Plaza,17304,Preston Road